Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis

2020 ◽  
Author(s):  
Jun Omatsu ◽  
Ryosuke Saigusa ◽  
Takuya Miyagawa ◽  
Yuki Fukui ◽  
Satoshi Toyama ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Skin Sclerosis

Serum LL-37 levels correlate with the efficacy of i.v. cyclophosphamide pulse for skin sclerosis and interstitial lung disease in systemic sclerosis

2017 ◽  
Vol 44 (4) ◽  
pp. 468-469 ◽  
Author(s):  
Takehiro Takahashi ◽  
Yoshihide Asano ◽  
Takashi Taniguchi ◽  
Ayumi Yoshizaki ◽  
Shinichi Sato
Keyword(s):  
Systemic Sclerosis ◽  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Skin Sclerosis ◽  
Cyclophosphamide Pulse

scholarly journals Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease

2019 ◽  
Vol 15 (10) ◽  
pp. 1009-1017 ◽  
Author(s):  
Oliver Distler ◽  
Elizabeth R. Volkmann ◽  
Anna Maria Hoffmann-Vold ◽  
Toby M. Maher
Keyword(s):  
Systemic Sclerosis ◽  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Future Perspectives

scholarly journals Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

2019 ◽  
Vol 380 (26) ◽  
pp. 2518-2528 ◽  
Author(s):  
Oliver Distler ◽  
Kristin B. Highland ◽  
Martina Gahlemann ◽  
Arata Azuma ◽  
Aryeh Fischer ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Interstitial Lung Disease ◽  
Lung Disease
Sign in / Sign up

Export Citation Format

Share Document